NCH93 LUC2 NF2−/− cells engraft in NSG mice with ANXA3 KD showed reduced tumour growth after 29 days, as monitored by the IVIS imaging system compared to SCR controls (Fig. 7d). The gene discussed is NF2; the disease is neoplasm.